Cargando…

EHMTI-0033. The phosphodiesterase 3 inhibitor cilostazol induces migraine-like attacks via cAMP increase

Detalles Bibliográficos
Autores principales:	Song, G, Olesen, J, Ashina, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2014
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181428/ http://dx.doi.org/10.1186/1129-2377-15-S1-A5

Ejemplares similares

EHMTI-0111. Intra-variability of migraine attacks features
por: Viana, M, et al.
Publicado: (2014)

EHMTI-0230. Characteristics of menstrual and nonmenstrual migraine attacks in women with menstrual migraine
por: Vetvik, KG, et al.
Publicado: (2014)

EHMTI-0044. Variability of clinical features in attacks of migraine with aura
por: Hansen, J Møller, et al.
Publicado: (2014)

EHMTI-0036. Gammacore device for treatment of migraine attack: preliminary report
por: Grazzi, L, et al.
Publicado: (2014)

EHMTI-0193. The impact of cognitive symptoms on migraine attack related disability
por: Gil-Gouveia, R, et al.
Publicado: (2014)

EHMTI-0174. Dural vessel hemodynamics during normal behavior and migraine attack
por: Gao, Y, et al.
Publicado: (2014)

EHMTI-0377. The influence of genetic constitution on migraine drug responses
por: Christensen, AF, et al.
Publicado: (2014)

Phosphodiesterase (PDE) III inhibitor, Cilostazol, improved memory impairment in aluminum chloride-treated rats: modulation of cAMP/CREB pathway
por: Khalifa, Mona, et al.
Publicado: (2022)

EHMTI-0318. The place of corticosteroids in migraine attack management: systematic review and critical appraisal
por: Woldeamanuel, YW, et al.
Publicado: (2014)

EHMTI-0372. No abnormalities of intrinsic brain connectivity during the interictal phase of migraine with aura
por: Hougaard, A, et al.
Publicado: (2014)

Correction to: Phosphodiesterase (PDE) III inhibitor, Cilostazol, improved memory impairment in aluminum chloride-treated rats: modulation of cAMP/CREB pathway
por: Khalifa, Mona, et al.
Publicado: (2022)

Prostaglandin E2 induces immediate migraine-like attack in migraine patients without aura
por: Antonova, M, et al.
Publicado: (2013)

EHMTI-0380. The association of migraine susceptibility loci with severe migraine characteristics in a clinic-based migraine sample
por: Esserlind, A, et al.
Publicado: (2014)

EHMTI-0186. Multi-center 3T MRI study of cortical thickness abnormalities in migraine
por: Magon, S, et al.
Publicado: (2014)

EHMTI-0146. Topiramate in migraine prevention
por: Ristic, S, et al.
Publicado: (2014)

Cilostazol induced migraine does not respond to sumatriptan in a double blind trial
por: Falkenberg, Katrine, et al.
Publicado: (2018)

EHMTI-0104. VIP levels in peripheral blood outside migraine attacks as a potential biomarker of cranial parasympathetic activation in chronic migraine
por: Cernuda-Morollón, E, et al.
Publicado: (2014)

EHMTI-0181. Fast recovery of visual evoked potential amplitude after photostress in migraine patients between attacks
por: Coppola, G, et al.
Publicado: (2014)

EHMTI-0125. Studying the permeability of the blood-brain barrier during migraine attacks using [11C]-dihydroergotamine
por: Schankin, C, et al.
Publicado: (2014)

Inhibition of cAMP phosphodiesterase by milrinone improves cardiac recovery after deep hypothermic circulatory arrest
por: Troitzsch, D, et al.
Publicado: (2001)

EHMTI-0203. Increased prevalence of migraine without aura in patients with saccular intracranial aneurysms (SIA) and remission after clipping of the aneurysm
por: Lebedeva, ER, et al.
Publicado: (2014)

EHMTI-0086. Pure mestrual vestibular migraine
por: Mostardini, C, et al.
Publicado: (2014)

EHMTI-0049. Headache, migraine and epileptic seizures
por: Gligic, N, et al.
Publicado: (2014)

EHMTI-0089. Relationship of sleep bruxism and migraine
por: Kato, M, et al.
Publicado: (2014)

Phosphodiesterases and cAMP Pathway in Pituitary Diseases
por: Bizzi, Mariana Ferreira, et al.
Publicado: (2019)

EHMTI-0122. Serum micrornas as potential biomarkers of migraine
por: Andersen, HH, et al.
Publicado: (2014)

EHMTI-0107. Treatment of migraine in Croatia, year 2013
por: Cvetkovic, V Vukovic, et al.
Publicado: (2014)

EHMTI-0358. Improved chronic migraine after DTMS
por: Scatena, P, et al.
Publicado: (2014)

EHMTI-0348. Refractive errors in patients with migraine headache
por: Gunes, A, et al.
Publicado: (2014)

EHMTI-0050. Systemic and cerebral endothelial function in migraine
por: Zaletel, M, et al.
Publicado: (2014)

EHMTI-0189. Tryptophan-kynurenine metabolism in migraine patients
por: Majláth, Z, et al.
Publicado: (2014)

EHMTI-0070. Effect of occlusal sprint in migraine patients
por: Takeuchi, M, et al.
Publicado: (2014)

EHMTI-0374. Gene-based pleiotropy across migraine with and migraine without aura
por: Nyholt, D, et al.
Publicado: (2014)

EHMTI-0368. Treatment of migraine attacks as suggested by Dr. John R. Graham in 1955. A historical analysis with current implications
por: Tfelt-Hansen, P, et al.
Publicado: (2014)

EHMTI-0224. Occipital nerve stimulation for drug-resistant chronic migraine: increasing experience
por: Bermejo, PE, et al.
Publicado: (2014)

EHMTI-0119. Increased prevalence of migraine in patients with unruptured saccular intracranial aneurysms (SIA)
por: Hambardzumyan, HD, et al.
Publicado: (2014)

EHMTI-0393. Abnormal ictal large-scale network connectivity in migraine without aura: a resting-state functional connectivity study
por: Amin, FM, et al.
Publicado: (2014)

EHMTI-0229. A case of migraine like headache with postprandial hypoglycemia treated with lifestyle changing
por: Candan, F Un
Publicado: (2014)

Evaluation of Antidepressant and Anxiolytic Activity of Phosphodiesterase 3 Inhibitor - Cilostazol
por: Patel, Dipesh S., et al.
Publicado: (2012)

EHMTI-0187. A novel ATP1A2 mutation in a case of familial hemiplegic migraine with especially severe attacks
por: Martínez, E, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_974cu74l3b22scnk3pad6d5msc